Dinetrel 100 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

dinetrel 100 mg

morningside healthcare (malta) limited - amantadinhydroklorid - kapsel, hard - 100 mg

Purimmun 50 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

purimmun 50 mg

2care4 generics aps - merkaptopurin - tablett - 50 mg

Buprefarm 30 mikrog/ time 노르웨이 - 노르웨이어 - Statens legemiddelverk

buprefarm 30 mikrog/ time

orifarm generics a/s - buprenorfin - depotplaster - 30 mikrog/ time

Calcipotriol/Betamethasone Orifarm 50 mikrog/ g / 0.5 mg/ g 노르웨이 - 노르웨이어 - Statens legemiddelverk

calcipotriol/betamethasone orifarm 50 mikrog/ g / 0.5 mg/ g

orifarm generics a/s - kalsipotriolmonohydrat / betametasondipropionat - gel - 50 mikrog/ g / 0.5 mg/ g

Esomeprazol Orifarm 10 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

esomeprazol orifarm 10 mg

orifarm generics a/s - esomeprazolmagnesium - enterogranulat til mikstur, suspensjon i dosepose - 10 mg

Sitagliptin / Metformin hydrochloride Mylan 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple kombinasjon terapi) som et tillegg til diett og trening hos pasienter ikke kontrollert på deres maksimal tolerert dose av metformin og en sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Dimethyl fumarate Mylan 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Oxycodone Orifarm 1 mg/ ml 노르웨이 - 노르웨이어 - Statens legemiddelverk

oxycodone orifarm 1 mg/ ml

orifarm generics a/s - oksykodonhydroklorid - mikstur, oppløsning - 1 mg/ ml

Oxycodone Orifarm 10 mg/ ml 노르웨이 - 노르웨이어 - Statens legemiddelverk

oxycodone orifarm 10 mg/ ml

orifarm generics a/s - oksykodonhydroklorid - mikstur, oppløsning - 10 mg/ ml

Pirfenidone Viatris 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

pirfenidone viatris

viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressive - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).